Zeitschriftenartikel (22)

2019
Zeitschriftenartikel
Scire, J.; Hozé, N.; Uecker, H.: Aggressive or moderate drug therapy for infectious diseases? Trade-offs between different treatment goals at the individual and population levels. PLoS Computational Biology 15 (8), e1007223 (2019)
2018
Zeitschriftenartikel
Uecker, H.: Effectively Evolution-proof Antibiotics? Trends in Microbiology 26 (12), S. 969 - 970 (2018)

Konferenzbericht (1)

2025
Konferenzbericht
Uecker, H.: Meeting report on the symposium “Evolutionary Applications” at the 3rd Joint Congress on evolutionary biology. The 3rd Joint Congress on Evolutionary Biology, Virtual, 28. Juni 2024. Evolutionary Applications 18 (3), e70082 Aufl., S. 1 - 9 (2025)

Hochschulschrift - Doktorarbeit (3)

2025
Hochschulschrift - Doktorarbeit
Dewan, I. A.: Models of evolutionary rescue of bacteria and yeast by extrachromosomal genetic elements. Dissertation, x,149 S., Christian-Albrechts-Universität, Kiel (2025)
2023
Hochschulschrift - Doktorarbeit
Nyhoegen, C.: Another bug bites the dust: Mathematical models for multi-drug treatments of bacterial infections. Dissertation, 199 S., Christian-Albrechts-Universität, Kiel (2023)
2022
Hochschulschrift - Doktorarbeit
Santer, M.: The more, the merrier? Population genetics theory for bacteria carrying multicopy replicons. Dissertation, 187 S., Christian-Albrechts-Universität, Kiel (2022)

Hochschulschrift - Master (1)

2021
Hochschulschrift - Master
Deraje, P.: Stochastic processes and population genetics. Master, Indian Institute of Science Education and Research, Mohali (2021)

Forschungspapier (2)

2025
Forschungspapier
Batra, A.; Tueffers, L.; Haas, K.; Loeblein, T.; Botelho, J.; Habig, M.; Schuetz, D.; Sakalyte, G.; Buchholz, F.; Berríos-Caro, E. et al.; Uecker, H.; Unterweger, D.; Schulenburg, H.: Resistance variation and bacterial interactions shape the adaptation of a genetically diverse bacterial population to antimicrobial treatment. (2025)
2024
Forschungspapier
Kippnich, J.; Benz, F.; Uecker, H.; Baumdicker, F.: Effectiveness of CRISPR-Cas in sensitizing bacterial populations with plasmid-encoded antimicrobial resistance. (2024)
Zur Redakteursansicht